Zai Lab accelerates innovative drug launches in China through partnerships and expertise, targeting $1.5-$2B revenue by 2028.

D-Wave Quantum's promising growth is tempered by high valuations and market risks. Learn why QBTS stock is now rated Hold ...

Edward Kellman, CEO and chief design engineer of Trakker Apps, holds two U.S. patents for an innovative take on double-entry ...

Q1 2025 Earnings Call Transcript May 27, 2025 BioLineRx Ltd. beats earnings expectations. Reported EPS is $1.39, expectations ...

BLRX READ THE FULL BLRX RESEARCH REPORT BioLineRx Ltd. (NASDAQ:BLRX) reported first quarter 2025 results, producing license revenues of $255,000. Following the transition of commercialization ...

We love linen for its natural temperature-regulating properties and durability. The best linen sheets include soft, cooling, ...

ASX health stocks have had a strong week with a wave of capital raisings in the sector as firms seek to strengthen their balance sheets.

"The mining companies were forced to abandon all activities immediately, and make good any initial damage ... Nevertheless, ...

Elon Musk is criticizing President Donald Trump’s “big, beautiful bill,” exposing a significant fracture in a partnership ...

Boeing (BA 0.23%) stock is up around 14% so far this year, and analysts have been raising their price targets after the company reported a narrower-than-expected first-quarter los ...

NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting ...

The Company's focus on premium quality, innovation, and operational execution has driven consistent growth, with Q1 2025 ...